10.1097/01.brs.0000216593.97157.dd
Sources Food and Drug Administration (FDA): FDA Approves New Medication for Chronic Weight Management Molecular Metabolism Journal: Glucagon-like peptide 1 (GLP-1) American Gastroenterological Association (AGA): Biology of Incretins: GLP-1 and GIP Columbia Surgery: The Ozempic Effect: Everything You Need to Know About Medical Weight Loss Eli Lilly: Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies American Diabetes Association (ADA): Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes Important Medical Information and Disclaimers Important Current Status Update : As of March 19, 2025, the FDA has ended enforcement discretion for compounded tirzepatide
This is a titration strategy, not a permanent dosing change
Tirzepatide can also disrupt sleep through GI discomfort, nausea, and the general metabolic shifts that accompany rapid weight loss
Like if we lose weight too quickly, we can see subsequent muscle loss with this
Wegovy carries a significantly higher retail price, often exceeding $900$1,300 monthly for brand-name semaglutide, even with insurance
